RESPOC

"Fast, cost-effective, user-friendly point of care (POC) instrument for detection of respiratory pathogens, including Streptococcus pneumoniae"

Coordinatore	ATEKNEA SOLUTIONS CATALONIA, SA    more  Organization address address: CALLE VICTOR PRADERA 45 city: CORNELLA DE LLOBREGAT BARCELONA postcode: 8940 contact info Titolo: Ms. Nome: Alicja Cognome: Grzegorzek Email: send email Telefono: +34 93 204 9922
Nazionalità Coordinatore	Spain [ES]
Totale costo	1˙465˙823 €
EC contributo	1˙102˙097 €
Programma	FP7-SME Specific Programme "Capacities": Research for the benefit of SMEs
Code Call	FP7-SME-2013
Funding Scheme	BSG-SME
Anno di inizio	2013
Periodo (anno-mese-giorno)	2013-12-01   -   2016-05-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	ATEKNEA SOLUTIONS CATALONIA, SA  Organization address address: CALLE VICTOR PRADERA 45 city: CORNELLA DE LLOBREGAT BARCELONA postcode: 8940 contact info Titolo: Ms. Nome: Alicja Cognome: Grzegorzek Email: send email Telefono: +34 93 204 9922	ES (CORNELLA DE LLOBREGAT BARCELONA)	coordinator	51˙836.65
2	N.T. LABORATORY SRL  Organization address address: VIA ARNO 23/25 city: SESTO FIORENTINO postcode: 50019 contact info Titolo: Dr. Nome: Matteo Cognome: Fallani Email: send email Telefono: +39 055 374 083	IT (SESTO FIORENTINO)	participant	255˙439.25
3	LIONEX GMBH  Organization address address: Salzdahlumer Strasse 196 city: BRAUNSCHWEIG postcode: 38126 contact info Titolo: Prof. Nome: Mahavir Cognome: Singh Email: send email Telefono: +49 531 260 12 66 Fax: 495316000000	DE (BRAUNSCHWEIG)	participant	249˙771.22
4	JCB. ELECTROMECANICA SL  Organization address address: CALLE VICTOR PRADERA 45 city: CORNELLA DE LLOBREGAT postcode: 8940 contact info Titolo: Mr. Nome: Narcís Cognome: Clavell Email: send email Telefono: +34 93 204 9922	ES (CORNELLA DE LLOBREGAT)	participant	248˙108.20
5	SURESCREEN DIAGNOSTICS LIMITED  Organization address address: PRIME PARKWAY 1 PRIME ENTERPRISE 1 city: DERBY postcode: DE1 3QB contact info Titolo: Mr. Nome: Alex Cognome: Campbell Email: send email Telefono: +44 1332 830990	UK (DERBY)	participant	237˙947.13
6	HAHN-SCHICKARD-GESELLSCHAFT FUER ANGEWANDTE FORSCHUNG E.v.  Organization address address: WILHELM-SCHICKARD-STRASSE 10 city: Villingen postcode: 78052 contact info Titolo: Mrs. Nome: Saskia Cognome: Becker Email: send email Telefono: +49 7721 943158	DE (Villingen)	participant	32˙994.00
7	Nome Ente NON disponibile  Organization address address: PASEO SANT JOAN DE DEU 2 city: ESPLUGUES DE LLOBREGAT postcode: 8950 contact info Titolo: Ms Nome: Arnalte Cognome: Roser Email: send email Telefono: +34 936009751	ES (ESPLUGUES DE LLOBREGAT)	participant	26˙000.82

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Molecular techniques such as PCR (polymerase chain reaction) are becoming increasingly used for the detection of respiratory pathogens, due to their high accuracy and relatively fast turnaround time (hours). Their utilization can result in early and specific treatment, contribute to better patient outcomes and reduce length of hospital stay. However, implementation of rapid molecular diagnostics remains limited to large, centralised laboratories which can afford the requirements of dedicated PCR laboratory space, specialized personnel and costly equipment and consumables. Even in central laboratories, timely diagnosis may be undermined by delays during sample transport to the setting and batching practices oriented to save consumables. There is a need for a fast, cost-effective, user-friendly molecular diagnostic point-of-care (POC) instrument for near-patient use at small to medium size hospitals, and decentralized clinical laboratories. The RESPOC platform will be a novel solution designed to detect bacterial and viral respiratory pathogens in less than one hour. Based on the development of DNA extraction and DNA amplification methods integrated into a low-cost microfluidic lab-on-a-chip (LoC) consumable, the platform will deliver results automatically by insertion of the disposable LoC into a small footprint reading instrument. Initially it will identify the target respiratory pathogens Streptococcus pneumoniae (pneumococcus) and Bordetella pertussis. Pre-clinical validation and demonstration of the RESPOC instrument will be performed at the facilities of the RTD hospital participant and at the facilities of the SME end-users to ensure adequate diagnostic performance and usability.'